Xylazine and Wound Care
Harm Reduction 2.0: Unsafe Supply: Clinical Practice Implications and Future Directions | Anna McConnell, FNP-BC, and Kinna Thakarar, DO | June 7, 2023
Join Anna McConnell, FNP-BC, and Kinna Thakarar, DO, for Unsafe Supply: Clinical Practice Implications & Future Directions.
- Review the epidemiology of overdoses and infectious complications of substance use in Maine
- Recognize the significance of unsafe supply, with contaminants such as xylazine, and its clinical implications
- Identify opportunities to advocate for safe supply, such as community drug checking programs